Cancer Genome Sequencing Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Cancer Genome Sequencing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Genome Sequencing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Genome Sequencing Overall Market Size
2.1 Global Cancer Genome Sequencing Market Size: 2021 VS 2027
2.2 Global Cancer Genome Sequencing Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Genome Sequencing Players in Global Market
3.2 Top Global Cancer Genome Sequencing Companies Ranked by Revenue
3.3 Global Cancer Genome Sequencing Revenue by Companies
3.4 Top 3 and Top 5 Cancer Genome Sequencing Companies in Global Market, by Revenue in 2020
3.5 Global Companies Cancer Genome Sequencing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Genome Sequencing Players in Global Market
3.6.1 List of Global Tier 1 Cancer Genome Sequencing Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Genome Sequencing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Genome Sequencing Market Size Markets, 2021 & 2027
4.1.2 Second Generation
4.1.3 Third Generation
4.2 By Type - Global Cancer Genome Sequencing Revenue & Forecasts
4.2.1 By Type - Global Cancer Genome Sequencing Revenue, 2016-2021
4.2.2 By Type - Global Cancer Genome Sequencing Revenue, 2022-2027
4.2.3 By Type - Global Cancer Genome Sequencing Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Genome Sequencing Market Size, 2021 & 2027
5.1.2 Treatment
5.1.3 Research
5.2 By Application - Global Cancer Genome Sequencing Revenue & Forecasts
5.2.1 By Application - Global Cancer Genome Sequencing Revenue, 2016-2021
5.2.2 By Application - Global Cancer Genome Sequencing Revenue, 2022-2027
5.2.3 By Application - Global Cancer Genome Sequencing Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Cancer Genome Sequencing Market Size, 2021 & 2027
6.2 By Region - Global Cancer Genome Sequencing Revenue & Forecasts
6.2.1 By Region - Global Cancer Genome Sequencing Revenue, 2016-2021
6.2.2 By Region - Global Cancer Genome Sequencing Revenue, 2022-2027
6.2.3 By Region - Global Cancer Genome Sequencing Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Cancer Genome Sequencing Revenue, 2016-2027
6.3.2 US Cancer Genome Sequencing Market Size, 2016-2027
6.3.3 Canada Cancer Genome Sequencing Market Size, 2016-2027
6.3.4 Mexico Cancer Genome Sequencing Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Cancer Genome Sequencing Revenue, 2016-2027
6.4.2 Germany Cancer Genome Sequencing Market Size, 2016-2027
6.4.3 France Cancer Genome Sequencing Market Size, 2016-2027
6.4.4 U.K. Cancer Genome Sequencing Market Size, 2016-2027
6.4.5 Italy Cancer Genome Sequencing Market Size, 2016-2027
6.4.6 Russia Cancer Genome Sequencing Market Size, 2016-2027
6.4.7 Nordic Countries Cancer Genome Sequencing Market Size, 2016-2027
6.4.8 Benelux Cancer Genome Sequencing Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Cancer Genome Sequencing Revenue, 2016-2027
6.5.2 China Cancer Genome Sequencing Market Size, 2016-2027
6.5.3 Japan Cancer Genome Sequencing Market Size, 2016-2027
6.5.4 South Korea Cancer Genome Sequencing Market Size, 2016-2027
6.5.5 Southeast Asia Cancer Genome Sequencing Market Size, 2016-2027
6.5.6 India Cancer Genome Sequencing Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Cancer Genome Sequencing Revenue, 2016-2027
6.6.2 Brazil Cancer Genome Sequencing Market Size, 2016-2027
6.6.3 Argentina Cancer Genome Sequencing Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Genome Sequencing Revenue, 2016-2027
6.7.2 Turkey Cancer Genome Sequencing Market Size, 2016-2027
6.7.3 Israel Cancer Genome Sequencing Market Size, 2016-2027
6.7.4 Saudi Arabia Cancer Genome Sequencing Market Size, 2016-2027
6.7.5 UAE Cancer Genome Sequencing Market Size, 2016-2027
7 Players Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Corporate Summary
7.1.2 Agilent Technologies Business Overview
7.1.3 Agilent Technologies Cancer Genome Sequencing Major Product Offerings
7.1.4 Agilent Technologies Cancer Genome Sequencing Revenue in Global (2016-2021)
7.1.5 Agilent Technologies Key News
7.2 GE Healthcare Life Sciences
7.2.1 GE Healthcare Life Sciences Corporate Summary
7.2.2 GE Healthcare Life Sciences Business Overview
7.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Major Product Offerings
7.2.4 GE Healthcare Life Sciences Cancer Genome Sequencing Revenue in Global (2016-2021)
7.2.5 GE Healthcare Life Sciences Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Cancer Genome Sequencing Major Product Offerings
7.3.4 Johnson & Johnson Cancer Genome Sequencing Revenue in Global (2016-2021)
7.3.5 Johnson & Johnson Key News
7.4 LI-COR Biosciences
7.4.1 LI-COR Biosciences Corporate Summary
7.4.2 LI-COR Biosciences Business Overview
7.4.3 LI-COR Biosciences Cancer Genome Sequencing Major Product Offerings
7.4.4 LI-COR Biosciences Cancer Genome Sequencing Revenue in Global (2016-2021)
7.4.5 LI-COR Biosciences Key News
7.5 Abbott Laboratories
7.5.1 Abbott Laboratories Corporate Summary
7.5.2 Abbott Laboratories Business Overview
7.5.3 Abbott Laboratories Cancer Genome Sequencing Major Product Offerings
7.5.4 Abbott Laboratories Cancer Genome Sequencing Revenue in Global (2016-2021)
7.5.5 Abbott Laboratories Key News
7.6 Beckman Coulter
7.6.1 Beckman Coulter Corporate Summary
7.6.2 Beckman Coulter Business Overview
7.6.3 Beckman Coulter Cancer Genome Sequencing Major Product Offerings
7.6.4 Beckman Coulter Cancer Genome Sequencing Revenue in Global (2016-2021)
7.6.5 Beckman Coulter Key News
7.7 Bayer
7.7.1 Bayer Corporate Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Cancer Genome Sequencing Major Product Offerings
7.4.4 Bayer Cancer Genome Sequencing Revenue in Global (2016-2021)
7.7.5 Bayer Key News
7.8 Hamilton Thorne Biosciences
7.8.1 Hamilton Thorne Biosciences Corporate Summary
7.8.2 Hamilton Thorne Biosciences Business Overview
7.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Major Product Offerings
7.8.4 Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue in Global (2016-2021)
7.8.5 Hamilton Thorne Biosciences Key News
7.9 Integrated DNA Technologies
7.9.1 Integrated DNA Technologies Corporate Summary
7.9.2 Integrated DNA Technologies Business Overview
7.9.3 Integrated DNA Technologies Cancer Genome Sequencing Major Product Offerings
7.9.4 Integrated DNA Technologies Cancer Genome Sequencing Revenue in Global (2016-2021)
7.9.5 Integrated DNA Technologies Key News
7.10 Microchip Biotechnologies
7.10.1 Microchip Biotechnologies Corporate Summary
7.10.2 Microchip Biotechnologies Business Overview
7.10.3 Microchip Biotechnologies Cancer Genome Sequencing Major Product Offerings
7.10.4 Microchip Biotechnologies Cancer Genome Sequencing Revenue in Global (2016-2021)
7.10.5 Microchip Biotechnologies Key News
7.11 Myriad Genetics
7.11.1 Myriad Genetics Corporate Summary
7.11.2 Myriad Genetics Business Overview
7.11.3 Myriad Genetics Cancer Genome Sequencing Major Product Offerings
7.11.4 Myriad Genetics Cancer Genome Sequencing Revenue in Global (2016-2021)
7.11.5 Myriad Genetics Key News
7.12 Commonwealth Biotechnologies
7.12.1 Commonwealth Biotechnologies Corporate Summary
7.12.2 Commonwealth Biotechnologies Business Overview
7.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Major Product Offerings
7.12.4 Commonwealth Biotechnologies Cancer Genome Sequencing Revenue in Global (2016-2021)
7.12.5 Commonwealth Biotechnologies Key News
7.13 ZS Genetics
7.13.1 ZS Genetics Corporate Summary
7.13.2 ZS Genetics Business Overview
7.13.3 ZS Genetics Cancer Genome Sequencing Major Product Offerings
7.13.4 ZS Genetics Cancer Genome Sequencing Revenue in Global (2016-2021)
7.13.5 ZS Genetics Key News
7.14 Pacific Biosciences
7.14.1 Pacific Biosciences Corporate Summary
7.14.2 Pacific Biosciences Business Overview
7.14.3 Pacific Biosciences Cancer Genome Sequencing Major Product Offerings
7.14.4 Pacific Biosciences Cancer Genome Sequencing Revenue in Global (2016-2021)
7.14.5 Pacific Biosciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Cancer Genome Sequencing Market Opportunities & Trends in Global Market
Table 2. Cancer Genome Sequencing Market Drivers in Global Market
Table 3. Cancer Genome Sequencing Market Restraints in Global Market
Table 4. Key Players of Cancer Genome Sequencing in Global Market
Table 5. Top Cancer Genome Sequencing Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Cancer Genome Sequencing Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Cancer Genome Sequencing Revenue Share by Companies, 2016-2021
Table 8. Global Companies Cancer Genome Sequencing Product Type
Table 9. List of Global Tier 1 Cancer Genome Sequencing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Genome Sequencing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Agilent Technologies
GE Healthcare Life Sciences
Johnson & Johnson
LI-COR Biosciences
Abbott Laboratories
Beckman Coulter
Bayer
Hamilton Thorne Biosciences
Integrated DNA Technologies
Microchip Biotechnologies
Myriad Genetics
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences